Evidence map›Paper›PMID 42367197›Full record

ArticleProceedings. IEEE International Symposium on Biomedical Imaging2026

LEARNABLE HIERARCHICAL VISUAL CONTEXTS FOR TUMOR SEGMENTATION IN COMPUTED TOMOGRAPHY IMAGES.

Jue Jiang, Harini Veeraraghavan

Abstract read
In one paragraph

Article in Proceedings. IEEE International Symposium on Biomedical Imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jue JiangDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, 10065 NY, USA.
Harini VeeraraghavanDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, 10065 NY, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Safer lung cancer radiotherapy delivery using novel artificial intelligence methodsR01CA258821 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Harini Veeraraghavan · 2022 to 2026
$2.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA258821
6 · The paper itself

Abstract

Despite advances in deep learning (DL), automated tumor segmentation on computed tomography (CT) scans remains challenging for radiotherapy applications due to due to large variability in tumor shapes, appearance, and diffuse boundaries. We present LeVal-learnable visual query contexts that refines attention towards tumor-relevant regions for improved segmentation. LeVal combines task-agnostic learnable tokens called semantic contexts with task-specific query tokens. Semantic contexts cross attend to multi-scale features of a 3D Swin transformer encoder, which are jointly subject to 2-stage pretraining: (a) self-supervised learning (SSL) using 14,000 unlabeled CTs and (b), supervised pretraining for multi-organ segmentation use pseudo-contours generated by bespoke methods. Task queries are refined through cross-attention with semantic contexts, which then modulate the decoder output to generate segmentation. LeVal was evaluated across four public datasets involving pancreas, colon, adrenal, and head-and-neck cancers. It consistently outperformed existing methods. Leval also demonstrated stronger embedding separation between tumor and surrounding healthy tissues, indicating better discriminability. Code and model checkpoints will be made available through GitHub upon manuscript acceptance.

Indexed as

Few-shot learningLearnable context tokensPretrainingTumor segmentationVision transformer

Identifiers

PMID42367197
PMCPMC13295008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.